Abbott Completes Separation of Research-Based Pharmaceuticals Business

Abbott Completes Separation of Research-Based Pharmaceuticals Business

[at noodls] – Abbott Park, Illinois – Abbott (NYSE: ABT) today announced it has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. … more

View todays social media effects on ABT

View the latest stocks trending across Twitter. Click to view dashboard

See who Abbott is hiring next, click here to view

Share this post